Soemiwati Holland, MD
Endocrinology, Diabetes & Metabolism · Jackson, NJNPI 1740549864
Payments from drug & device makers
Across 734 payments — averaging $23.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$7K
- Novo Nordisk$2K
- Abbott$1K
- Corcept Therapeutics$950
- Lilly USA, LLC$860
- Amgen$728
- plus $5K from 36 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 44 | $7,012 |
| Novo Nordisk | 189 | $2,150 |
| Abbott | 51 | $1,064 |
| Corcept Therapeutics | 58 | $950 |
| Lilly USA, LLC | 58 | $860 |
| Amgen(2 entities) | 48 | $728 |
| Mannkind Corporation | 37 | $683 |
| Dexcom, Inc. | 27 | $502 |
| AstraZeneca(2 entities) | 23 | $338 |
| AbbVie | 19 | $306 |
| Recordati_rare_diseases_inc. | 15 | $279 |
| Embecta Corp. | 17 | $217 |
| Amneal Pharmaceuticals LLC | 14 | $216 |
| Xeris Pharmaceuticals, Inc. | 15 | $202 |
| Insulet Corporation | 9 | $196 |
| Pfizer | 10 | $192 |
| Boehringer Ingelheim | 13 | $177 |
| Bayer | 10 | $172 |
| Medtronic(2 entities) | 10 | $165 |
| Ipsen Biopharmaceuticals, Inc | 6 | $108 |
| Ascendis Pharma Endocrinology Inc | 6 | $99 |
| UCB, Inc. | 7 | $96 |
| Madrigal Pharmaceuticals | 4 | $94 |
| IBSA Pharma Inc. | 7 | $90 |
| Chiesi USA, Inc. | 4 | $84 |
| Radius Health, Inc. | 5 | $80 |
| Antares Pharma, Inc. | 2 | $79 |
| Tandem Diabetes Care, Inc. | 4 | $73 |
| Amarin Pharma, Inc. | 3 | $43 |
| BD | 3 | $43 |
| Cequr Corporation | 1 | $39 |
| Ionis Pharmaceuticals, Inc. | 2 | $36 |
| Tolmar, Inc. | 2 | $33 |
| Amryt Pharma Holdings Ltd | 2 | $33 |
| Merck | 2 | $26 |
| Soleno Therapeutics, Inc. | 1 | $19 |
| Novartis | 1 | $17 |
| Rhythm Pharmaceuticals, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Ascensia Diabetes Care US Inc. | 1 | $14 |
| Viiv Healthcare Company | 1 | $14 |
| Lifescan, Inc. | 1 | $13 |
How this compares
$17,572 in reported general payments places this provider in the 85th percentile of 367 endocrinology, diabetes & metabolism providers in New Jersey.
See all endocrinology, diabetes & metabolism providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other endocrinology, diabetes & metabolism in Jackson
- Barry GertzRahway$903K
- Nawras MakhsidaRandolph$882K
- Marc SandbergFlemington$567K
- Joanne WaldstreicherNew Brunswick$441K
- Gregory BaroneCherry Hill$433K
- Taher ModarressiPennington$414K
- Navtika DesaiHillsborough$408K
- Atara SchultzTeaneck$357K
- Anthony CannonTurnersville$296K
- Sunil AsnaniBrick$295K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.